Regeneron Pharmaceuticals (REGN) — Stock Research & Financial Analysis

Regeneron is a US biotechnology company that discovers and develops medicines for serious diseases across multiple therapeutic areas. Its profile depends on scale, competitive position, demand trends, and margin execution.